• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS ESHEATH+ INTRODUCER; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS ESHEATH+ INTRODUCER; INTRODUCER, CATHETER Back to Search Results
Model Number 914ESPA
Device Problems Difficult to Advance (2920); Material Deformation (2976); Material Split, Cut or Torn (4008)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/17/2023
Event Type  malfunction  
Event Description
As reported by the field clinical specialist (fcs), during a transfemoral tavr procedure with a 23mm sapien 3 ultra valve, the commander delivery system and valve was getting caught at the common femoral artery, possibly at tract, during insertion within the esheath+.The operators dilated the tract with spreaders.The delivery system still would not advance after multiple attempts, so the devices were removed as a unit.During inspection of the removed devices, the 14fr esheath+ appeared to be torn at the level of the crimped valve.A new system was prepped and used.The valve was successfully implanted.There was no injury to the patient.Per images received, the strain relief was damaged, and a liner strand was observed.
 
Manufacturer Narrative
The device was not returned to edwards lifesciences for evaluation.However, fluoro imaging was provided by the site and device.The following was observed: procedural fluoro imagery shows the crimped valve and delivery system appearing within the sheath shaft at a bend in the access vessel, near the femoral head.Post procedural device imagery shows sheath shaft curvature, a liner tear with the crimped valve exposed through it, a liner strand, and strain relief damage.The 3mensio imaging report for the patient was provided and shows a tortuous access vessel with calcification present in the abdominal aorta.However, the calcification was unlikely a contributing factor due to location of the resistance.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The reported events were confirmed through provided imaging from the site.Available information suggests patient factors (tortuosity) and/or procedural factors (steep insertion angle) likely contributed to the resistance experienced inserting the delivery system through the sheath.Tortuous patient anatomy can create sub-optimal angles that can lead to non coaxial alignment between the delivery system with crimped valve and sheath inner lumen.A steep insertion angle can result in non coaxial alignment between the delivery system and sheath.Non coaxial advancement of the delivery system through the sheath may lead to resistance.It is possible that additional device manipulation to overcome the resistance may be applied during the procedure resulting in damage to the sheath.During delivery system advancement through a challenging pathway, it is possible that the devices may not be coaxially aligned.This can lead to the crimped valve to catch onto the sheath hdpe, liner, and/or strain relief and lead to damage.Excessive device manipulation applied to overcome the resistance can further damage the sheath through continued interaction between the crimped valve and sheath.Vessel tortuosity if present can exasperate the interaction between the crimped valve and sheath resulting in the damaged liner and strain relief.Therefore, available information suggests patient factors (tortuosity) and/or procedural factors (excessive manipulation, valve interaction with liner and strain relief) likely contributed to the sheath damages.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.As such, neither a product risk assessment, nor corrective or preventative actions are required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS ESHEATH+ INTRODUCER
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key18191986
MDR Text Key328807179
Report Number2015691-2023-17686
Device Sequence Number1
Product Code DYB
UDI-Device Identifier00690103215465
UDI-Public(01)00690103215465(17)250508(11)230509
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K200258
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number914ESPA
Device Lot Number65043112
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/09/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-